Roux‐en‐Y versus one‐anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial

Author:

Heinonen Sini12ORCID,Saarinen Tuure3,Meriläinen Sanna4,Sammalkorpi Henna3,Penttilä Anne K.3,Koivikko Minna5,Siira Pertti6,Karppinen Jaro7,Säiläkivi Ulla3,Rosengård‐Bärlund Milla8,Koivukangas Vesa4,Pietiläinen Kirsi H.18,Juuti Anne3

Affiliation:

1. Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine University of Helsinki and Helsinki University Hospital Helsinki Finland

2. Departement of Internal Medicine Helsinki University Hospital Helsinki Finland

3. Department of Gastrointestinal Surgery, Abdominal Center Helsinki University Hospital and University of Helsinki Helsinki Finland

4. Abdominal Center, Oulu University Hospital, Medical Research Center Oulu University of Oulu Oulu Finland

5. Center of Internal Medicine, Oulu University Hospital University of Oulu Oulu Finland

6. Department of Physical Medicine and Rehabilitation Oulu University Hospital Oulu Finland

7. Medical Research Center Oulu Oulu University Hospital and University of Oulu Oulu Finland

8. HealthyWeightHub, Endocrinology, Abdominal Center Helsinki University Hospital and University of Helsinki Helsinki Finland

Abstract

AbstractObjectiveAlthough it has been suggested that one‐anastomosis gastric bypass (OAGB) is metabolically superior to the “gold standard,” i.e., Roux‐en‐Y gastric bypass (RYGB), there is little robust evidence to prove it. Because this result may arise from the typically longer length of bypassed intestine in OAGB, here, the authors standardized the bypass length in RYGB and OAGB and compared weight loss and metabolic outcomes in a randomized controlled trial.MethodsThe authors randomized 121 bariatric patients to RYGB (n = 61) or OAGB (n = 60) in two Finnish University Hospitals and measured weight; body composition; metabolic features (insulin sensitivity, lipids, inflammation, nutrition); and comorbidities before and 6 and 12 months after the operation.ResultsTotal weight loss was similar in RYGB and OAGB at 6 months (mean: 21.2% [95% CI: 19.4–23.0] vs. 22.8% [95% CI: 21.5–24.1], p = 0.136) and 12 months (25.4% [95% CI: 23.4–27.5] vs. 26.1% [95% CI: 24.2–28.9], p = 0.635). Insulin sensitivity, lipids, and inflammation improved similarly between the groups (p > 0.05). Remission of type 2 diabetes and hypercholesterolemia was marked and similar (p > 0.05) but the use of antihypertensive medications was lower (p = 0.037) and hypertension tended to improve more (p = 0.053) with RYGB versus OAGB at 12 months. Higher rates of vitamin D‐25 deficiency (p < 0.05) and lower D‐25 levels were observed with OAGB versus RYGB throughout the follow‐up (p < 0.001). No differences in adverse effects were observed.ConclusionsRYGB and OAGB were comparable in weight loss, metabolic improvement, remission of diabetes and hypercholesterolemia, and nutrition at 1‐year follow‐up. Vitamin D‐25 deficiency was more prevalent with OAGB, whereas reduction in antihypertensive medications and hypertension was greater with RYGB. There is no need to change the current practices of RYGB in favor of OAGB.

Funder

Academy of Finland

Fondazione Diabete Ricerca

Helsingin Yliopisto

Novo Nordisk Fonden

Orionin Tutkimussäätiö

Paavo Nurmen Säätiö

Paulon Säätiö

Signe ja Ane Gyllenbergin Säätiö

Suomen Lääketieteen Säätiö

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3